Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Journal article
Adriano Vieira V. et al, (2023), JCI Insight
Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion.
Journal article
Jay C. et al, (2023), Front Immunol, 14
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Journal article
Huo J. et al, (2022), Cell Rep
Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
Journal article
Fidler S. et al, (2022), Clin Infect Dis
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
Journal article
Dolton G. et al, (2022), Cell, 185, 2936 - 2951.e19
Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatment
Journal article
Bengu N. et al, (2022), Medicine (United States), 101
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
Journal article
Fernández-Luis S. et al, (2022), BMC Public Health, 22
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
Journal article
Khan K. et al, (2022), Clinical Infectious Diseases, 75, E857 - E864
Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and with Human Immunodeficiency Virus on Antiretroviral Therapy during the First South African Infection Wave
Journal article
Snyman J. et al, (2022), Clinical Infectious Diseases, 75, E249 - E256
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Journal article
Nutalai R. et al, (2022), Cell
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J Immunol Methods, 504
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nat Commun, 13
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound.
Journal article
Zacharopoulou P. et al, (2022), Sci Rep, 12
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.
Journal article
Ruggiero A. et al, (2022), Front Immunol, 13
HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control.
Journal article
Fardoos R. et al, (2022), Front Immunol, 13
Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.
Journal article
Vieira VA. et al, (2022), Front Immunol, 13
Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts.
Journal article
Brown R. et al, (2022), Wellcome Open Res, 7
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
Journal article
Angyal A. et al, (2022), The Lancet Microbe, 3, e21 - e31